Recurrent Head and Neck Squamous Cell Cancer
1 clinical trials · Condition
◉ Watch Recurrent Head and Neck Squamous Cell Cancer
| Record | Firm | Date |
|---|---|---|
| Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer (NCT03667482) | Memorial Sloan Kettering Cancer Center | 2018-09-07 |
Track Recurrent Head and Neck Squamous Cell Cancer automatically
Every clearance here is in the API, with alerts when new ones post.